|
1.
|
Ozols RF: Treatment goals in ovarian
cancer. Int J Gynecol Cancer. 15(Suppl 1): 3–11. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Leung PC and Choi JH: Endocrine signaling
in ovarian surface epithelium and cancer. Hum Reprod Update.
13:143–162. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Rae MT, Niven D, Ross A, Forster T, Lathe
R, Critchley HOD, Ghazal P and Hillier SG: Steroid signalling in
human ovarian surface epithelial cells: the response to
interleukin-1alpha determined by microarray analysis. J Endocrinol.
183:19–28. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Papacleovoulou G, Hogg K, Fegan KS,
Critchley HO, Hillier SG and Mason JI: Regulation of
3beta-hydroxysteroid dehydrogenase type 1 and type 2 gene
expression and function in the human ovarian surface epithelium by
cytokines. Mol Hum Reprod. 15:379–392. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Ivarsson K, Sundfeldt K, Brannstrom M and
Janson PO: Production of steroids by human ovarian surface
epithelial cells in culture: possible role of progesterone as
growth inhibitor. Gynecol Oncol. 82:116–121. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Okamura H, Katabuchi H and Ohba T: What we
have learned from isolated cells from human ovary? Mol Cell
Endocrinol. 202:37–45. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Nash DM, Hess SA, White BA and Peluso JJ:
Steroidogenic factor-1 regulates the rate of proliferation of
normal and neoplastic rat ovarian surface epithelial cells in
vitro. Endocrinology. 139:4663–4671. 1998.PubMed/NCBI
|
|
8.
|
Batsche E, Desroches J, Bilodeau S,
Gauthier Y and Drouin J: Rb enhances p160/SRC coactivator-dependent
activity of nuclear receptors and hormone responsiveness. J Biol
Chem. 280:19746–19756. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Tran PV, Akana SF, Malkovska I, Dallman
MF, Parada LF and Ingraham HA: Diminished hypothalamic bdnf
expression and impaired VMH function are associated with reduced
SF-1 gene dosage. J Comp Neurol. 498:637–648. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Syed V, Ulinski G, Mok SC, Yiu GK and Ho
SM: Expression of gonadotropin receptor and growth responses to key
reproductive hormones in normal and malignant human ovarian surface
epithelial cells. Cancer Res. 61:6768–6776. 2001.
|
|
11.
|
Hinkula M, Pukkala E, Kyyrönen P and
Kauppila A: Incidence of ovarian cancer of grand multiparous women
- A population-based study in Finland. Gynecol Oncol. 103:207–211.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Sugawara T, Kiriakidou M, McAllister JM,
Holt JA, Arakane F and Strauss JF III: Regulation of expression of
the steroidogenic acute regulatory protein (StAR) gene: a central
role for steroidogenic factor 1. Steroids. 62:5–9. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Fujieda K, Tajima T, Nakae J, Sageshima S,
Tachibana K, Suwa S, Sugawara T and Strauss JF III: Spontaneous
puberty in 46,XX subjects with congenital lipoid adrenal
hyperplasia. Ovarian steroidogenesis is spared to some extent
despite inactivating mutations in the steroidogenic acute
regulatory protein (StAR) gene. J Clin Invest. 99:1265–1271. 1997.
View Article : Google Scholar
|
|
14.
|
Ramayya MS, Sheng M, Moroz K, Hill SM and
Rowan BG: Human steroidogenic factor-1 (hSF-1) regulates
progesterone biosynthesis and growth of ovarian surface epithelial
cancer cells. J Steroid Biochem Mol Biol. 119:14–25. 2010.
View Article : Google Scholar
|
|
15.
|
Abd-Elaziz M, Moriya T, Akahira J, Suzuki
T and Sasano H: StAR and progesterone producing enzymes
(3beta-hydroxysteroid dehydrogenase and cholesterol side-chain
cleavage cytochromes P450) in human epithelial ovarian carcinoma:
immunohistochemical and real-time PCR studies. Cancer Sci.
96:232–239. 2005. View Article : Google Scholar
|
|
16.
|
Taketo M, Parker KL, Howard TA, Tsukiyama
T, Wong M, Niwa O, Morton CC, Miron PM and Seldin MF: Homologs of
Drosophila Fushi-Tarazu factor 1 map to mouse chromosome 2
and human chromosome 9q33. Genomics. 25:565–567. 1995.
|
|
17.
|
Schultz DC, Vanderveer L, Buetow KH,
Boente MP, Ozols RF, Hamilton TC and Godwin AK: Characterization of
chromo-some 9 in human ovarian neoplasia identifies frequent
genetic imbalance on 9q and rare alterations involving 9p,
including CDKN2. Cancer Res. 55:2150–2157. 1995.
|
|
18.
|
Hoivik EA, Aumo L, Aesoy R, Lillefosse H,
Lewis AE, Perrett RM, Stallings NR, Hanley NA and Bakke M:
Deoxyribonucleic acid methylation controls cell type-specific
expression of steroidogenic factor 1. Endocrinology. 149:5599–5609.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Nakamura J, Kitajima Y, Kai K, Hashiguchi
K, Hiraki M, Noshiro H and Miyazaki K: Expression of hypoxic marker
CA IX is regulated by site-specific DNA methylation and is
associated with the histology of gastric cancer. Am J Pathol.
178:515–524. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Seidman JD, Russell P and Kurman RJ:
Surface epithelial tumors of the ovary. Blausten’s pathology of the
female genital tract. Kurman RJ: 5th ed. Springer; New York: pp.
791–904. 2002
|
|
21.
|
Despierre E, Lambrechts D, Neven P, Amant
F, Lambrechts S and Vergote I: The molecular genetic basis of
ovarian cancer and its roadmap towards a better treatment. Gynecol
Oncol. 117:358–365. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Chen JM, Cooper DN, Chuzhanova N, Férec C
and Patrinos GP: Gene conversion: mechanisms, evolution and human
disease. Nat Rev Genet. 8:762–775. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Xue Q, Lin Z, Yin P, Milad MP, Cheng YH,
Confino E, Reierstad S and Bulun SE: Transcriptional activation of
steroidogenic factor-1 by hypomethylation of the 5′ CpG island in
endometriosis. J Clin Endocrinol Metab. 92:3261–3267.
2007.PubMed/NCBI
|
|
24.
|
Balch C, Fang F, Matei DE, Huang TH and
Nephew KP: Minireview: epigenetic changes in ovarian cancer.
Endocrinology. 150:4003–4011. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Barton CA, Hacker NF, Clark SJ and O’Brien
PM: DNA methylation changes in ovarian cancer: implications for
early diagnosis, prognosis and treatment. Gynecol Oncol.
109:129–139. 2008. View Article : Google Scholar : PubMed/NCBI
|
